The general manager for Recordati Rare Diseases in MENA, Tony Zbeidy, explains why awareness of rare disorders has vastly improved in the region, which has one…
In Conversation
Ali Yehia, Country Manager for Viatris KSA, speaks about the company’s global operations and its plans for KSA, notably to play an active role in the…
Sanofi has been quick in the registration process thanks to its fantastic regulatory affairs department and has been able to launch products for multiple myeloma, different…
As a country, Saudi Arabia wants to match the well-established regulatory systems of North America, Europe, and Japan, but adding a halal component, which is of…
Today, international companies can see the value and the benefit of collaborating with Saudi businesses due to societal changes and government support
We are opening a new chapter in medicine. The early 2000s were focused on monoclonal antibodies, 2015 to 2025 is all about immune therapy, but 2025…
I really care about having operational people on the ground because, in the generics business, if you are not fast, you lose
Vision 2030 is a big opportunity, a north star that challenges each one of us to bring our best and contribute to Saudi Arabia's future
We have an important focus on the Saudi market and further expansion is planned from our side, strengthening our presence, expanding and growing the team while…
We will continue to diversify our partnerships and expand the geographical scope of our suppliers around the world
We hope that our new Saudi HTA agency, with the help of all other stakeholders such as our DPEC, will soon be fully functioning and generating…
The essence of all digitalization is data and this is our focus area moving forward. [We] must capture the right data, have data scientists articulate this…
